The present invention relates to amide derivatives which have blocking activities of voltage gated sodium channels as the Nav1.7 and Nav1.8 channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.
本发明涉及对电压门控
钠通道(如 Nav1.7 和 Nav1.8 通道)具有阻断活性的
酰胺衍
生物,它们可用于治疗或预防涉及电压门控
钠通道的紊乱和疾病。本发明还涉及包含这些化合物的药物组合物,以及这些化合物和组合物在预防或治疗涉及电压门控
钠通道的此类疾病中的用途。